NO20010804L - Muskariniske agonister og antagonister - Google Patents

Muskariniske agonister og antagonister

Info

Publication number
NO20010804L
NO20010804L NO20010804A NO20010804A NO20010804L NO 20010804 L NO20010804 L NO 20010804L NO 20010804 A NO20010804 A NO 20010804A NO 20010804 A NO20010804 A NO 20010804A NO 20010804 L NO20010804 L NO 20010804L
Authority
NO
Norway
Prior art keywords
antagonists
muscarinic agonists
muscarinic
agonists
Prior art date
Application number
NO20010804A
Other languages
English (en)
Norwegian (no)
Other versions
NO20010804D0 (no
Inventor
Gurmit Grewal
Anna Toy-Palmer
Xiong Cai
George Mark Latham
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Sa filed Critical Ucb Sa
Publication of NO20010804D0 publication Critical patent/NO20010804D0/no
Publication of NO20010804L publication Critical patent/NO20010804L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
NO20010804A 1998-08-18 2001-02-16 Muskariniske agonister og antagonister NO20010804L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9697798P 1998-08-18 1998-08-18
PCT/US1999/018570 WO2000011001A1 (en) 1998-08-18 1999-08-16 Muscarinic agonists and antagonists

Publications (2)

Publication Number Publication Date
NO20010804D0 NO20010804D0 (no) 2001-02-16
NO20010804L true NO20010804L (no) 2001-04-11

Family

ID=22260061

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010804A NO20010804L (no) 1998-08-18 2001-02-16 Muskariniske agonister og antagonister

Country Status (30)

Country Link
US (5) US6093724A (de)
EP (1) EP1112272B1 (de)
JP (1) JP2002523416A (de)
KR (1) KR20010072784A (de)
CN (1) CN1312812A (de)
AR (1) AR020199A1 (de)
AT (1) ATE227724T1 (de)
AU (1) AU750566B2 (de)
BG (1) BG105256A (de)
BR (1) BR9913072A (de)
CA (1) CA2340946A1 (de)
CO (1) CO5130018A1 (de)
DE (1) DE69903961T2 (de)
EE (1) EE200100096A (de)
ES (1) ES2191455T3 (de)
HK (1) HK1038918A1 (de)
HU (1) HUP0103203A3 (de)
ID (1) ID27544A (de)
IL (1) IL141050A0 (de)
IS (1) IS5827A (de)
NO (1) NO20010804L (de)
NZ (1) NZ509762A (de)
PE (1) PE20000988A1 (de)
PL (1) PL346247A1 (de)
RU (1) RU2219179C2 (de)
SK (1) SK1892001A3 (de)
TR (1) TR200100462T2 (de)
WO (1) WO2000011001A1 (de)
YU (1) YU13301A (de)
ZA (1) ZA200100978B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001292160A1 (en) * 2000-10-19 2002-04-29 Pfizer Products Inc. Bridged piperazine derivatives
GB0117950D0 (en) * 2001-02-16 2001-09-19 Aventis Pharma Inc Novel heterocyclic urea derivatives andd their use as dopamine D3 receptor ligands
WO2002094827A1 (en) * 2001-05-23 2002-11-28 Neurosearch A/S Fused tropane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
US20030064979A1 (en) * 2001-06-29 2003-04-03 Hansen Thomas Kruse Method of inhibiting PTP 1B and /or T-cell PTP and/or other PTPases with an Asp residue at position 48
US6828328B1 (en) * 2002-03-01 2004-12-07 Ucb S.A. Analgesic combination of muscarinic agonists
US7897766B2 (en) * 2005-09-23 2011-03-01 Abbott Laboratories Amino-aza-adamantane derivatives and methods of use
US8314119B2 (en) 2006-11-06 2012-11-20 Abbvie Inc. Azaadamantane derivatives and methods of use
US8076350B2 (en) 2006-12-22 2011-12-13 Abbott Laboratories Spirocyclic azaadamantane derivatives and methods of use
CA2679876A1 (en) 2007-03-23 2008-10-02 Abbott Laboratories 4-substituted azaadamantane derivatives and methods of use thereof
MX2009010175A (es) 2007-03-23 2009-10-12 Abbott Lab Derivados de acetamida y carboxamida de aza-adamantano y metodos de uso de los mismos.
PE20121066A1 (es) * 2009-06-19 2012-09-13 Abbvie Inc Derivados de diazahomoadamantano y metodos para usarlos
PT3061821T (pt) 2009-07-22 2019-09-05 PureTech Health LLC Composições para tratamento de distúrbios melhorados por ativação de recetores muscarínicos
US10265311B2 (en) 2009-07-22 2019-04-23 PureTech Health LLC Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
AR081626A1 (es) 2010-04-23 2012-10-10 Cytokinetics Inc Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
US9133123B2 (en) 2010-04-23 2015-09-15 Cytokinetics, Inc. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
CN103180321A (zh) * 2010-09-23 2013-06-26 Abbvie公司 氮杂金刚烷衍生物的一水合物
US8759380B2 (en) 2011-04-22 2014-06-24 Cytokinetics, Inc. Certain heterocycles, compositions thereof, and methods for their use
US12600726B2 (en) 2017-07-12 2026-04-14 Vanderbilt University Antagonists of the muscarinic acetylcholine receptor M4
IL310346A (en) 2017-10-20 2024-03-01 Univ Vanderbilt Muscarinic acetylcholine M4 receptor antagonists
EP3732163A4 (de) * 2017-12-20 2021-07-14 Vanderbilt University Antagonisten des muskarinischen acetylcholinrezeptors m4
KR102408292B1 (ko) 2018-09-28 2022-06-10 카루나 세러퓨틱스 인코포레이티드 무스카린성 수용체 활성화에 의해 개선된 장애의 치료를 위한 조성물 및 방법

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4739074A (en) * 1986-01-22 1988-04-19 Pennwalt Corporation Adamantane spiro-pyrrolidine derivatives
IL88156A (en) * 1987-11-13 1997-02-18 Novo Nordisk As Azacyclic compounds their preparation and pharmaceutical compositions containing them
US5527813A (en) * 1990-08-21 1996-06-18 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
WO1992011261A1 (en) * 1990-12-21 1992-07-09 Merck Sharp & Dohme Limited 4-azatricyclo[2.2.1.02,6]heptanes and pharmaceutical compositions
US5955470A (en) * 1991-06-11 1999-09-21 Merrell Pharmaceuticals, Inc. Derivatives of amide analogs of certain methano bridged quinolizines
US5641791A (en) * 1991-08-13 1997-06-24 Novo Nordisk A.S Heterocyclic compounds and their preparation and use
EE03566B1 (et) * 1995-11-02 2001-12-17 Neurosearch A/S Kondenseerunud tropaanderivaadid, nende valmistamine ja kasutamine
US5914338A (en) * 1996-04-02 1999-06-22 Novo Nordisk Heterocyclic compounds and their preparation and use
US5986100A (en) * 1998-04-02 1999-11-16 Crooks; Peter Anthony Pharmaceutical compositions and methods for use
US5952339A (en) * 1998-04-02 1999-09-14 Bencherif; Merouane Pharmaceutical compositions and methods of using nicotinic antagonists for treating a condition or disorder characterized by alteration in normal neurotransmitter release
US6057446A (en) * 1998-04-02 2000-05-02 Crooks; Peter Anthony Certain 1-aza-tricyclo [3.3.1-13,7 ] decane compounds

Also Published As

Publication number Publication date
BG105256A (en) 2001-11-30
TR200100462T2 (tr) 2001-09-21
IL141050A0 (en) 2002-02-10
US6423842B1 (en) 2002-07-23
PL346247A1 (en) 2002-01-28
PE20000988A1 (es) 2000-09-30
ATE227724T1 (de) 2002-11-15
KR20010072784A (ko) 2001-07-31
ES2191455T3 (es) 2003-09-01
US20020045617A1 (en) 2002-04-18
RU2219179C2 (ru) 2003-12-20
AU750566B2 (en) 2002-07-25
ID27544A (id) 2001-04-12
EP1112272A1 (de) 2001-07-04
ZA200100978B (en) 2002-02-05
DE69903961T2 (de) 2003-07-03
NZ509762A (en) 2002-12-20
US6323194B1 (en) 2001-11-27
EP1112272B1 (de) 2002-11-13
NO20010804D0 (no) 2001-02-16
HUP0103203A2 (hu) 2002-01-28
HK1038918A1 (zh) 2002-04-04
IS5827A (is) 2001-01-26
AU5775899A (en) 2000-03-14
CO5130018A1 (es) 2002-02-27
US6093724A (en) 2000-07-25
BR9913072A (pt) 2001-05-15
WO2000011001A1 (en) 2000-03-02
HUP0103203A3 (en) 2002-10-28
YU13301A (sh) 2005-06-10
CN1312812A (zh) 2001-09-12
US6251916B1 (en) 2001-06-26
CA2340946A1 (en) 2000-03-02
AR020199A1 (es) 2002-05-02
SK1892001A3 (en) 2001-11-06
DE69903961D1 (de) 2002-12-19
JP2002523416A (ja) 2002-07-30
EE200100096A (et) 2002-06-17
US6555550B1 (en) 2003-04-29

Similar Documents

Publication Publication Date Title
NO20010804D0 (no) Muskariniske agonister og antagonister
DK1076704T3 (da) IL-2-selektive agonister og antagonister
NO991151D0 (no) Forbindelse og anvendelse derav
NO20004778D0 (no) Amidderivater og nociceptin antagonister
DE69719354D1 (de) Muscarin-antagonisten
DE60031119D1 (de) Richtbohrvorrichtung und -verfahren
DE69918107D1 (de) Ionomere und ionenleitende zusammensetzungen
NO20022334L (no) Ny sammensetning og anvendelse
FI990534A0 (fi) CT-kuvauslaite
DK1454907T3 (da) Quninazolin og pyridopyrmidin-derivativer
IS6411A (is) Kaspasa tálmar og notkun þeirra
AR028385A1 (es) Agonistas muscarinicos
DE69901430D1 (de) Zentriereinrichtung
NO20006488D0 (no) Sammensetning og anvendelse
DK1112003T3 (da) Ny sammensætning og anvendelse
DE59904577D1 (de) Metallocenkomplexe
DE59914216D1 (de) Prüfsonde-Antriebsvorrichtung
DE69839736D1 (de) Pseudostereophonie-gerät
DE69926628D1 (de) Turbidimeterkalibrierung-überprüfungsvorrichtung
DE69919457D1 (de) Messtaster
DK1140952T3 (da) Phosphororganiske forbindelser og anvendelse heraf
DE69918215D1 (de) Bauteil-Tragvorrichtung
DE60009931D1 (de) Muscarin-antagonisten
ID30056A (id) Agonis-agonis 5-htif
NO990699D0 (no) Mikrotom

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application